Safety of Intervention by Cardiac Implantable Electronic Devices and Catheter Ablation in Patients on Anticoagulants
Not Applicable
- Conditions
- arrhythmia
- Registration Number
- JPRN-UMIN000038841
- Lead Sponsor
- ational Cerebral and Cardiovascular Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 9264
Inclusion Criteria
Not provided
Exclusion Criteria
none
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method procedure related complications
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How does anticoagulant therapy (e.g., NOACs, VKAs) interact with CIED implantation risks in arrhythmia patients?
What are the comparative safety outcomes of catheter ablation versus CIEDs in anticoagulated atrial fibrillation patients?
Which biomarkers (e.g., INR, platelet function) predict procedural complications in JPRN-UMIN000038841 arrhythmia study?
What thromboembolic or bleeding event rates are observed post-CIED/ablation in patients on direct oral anticoagulants?
How do molecular mechanisms of anticoagulants (e.g., Factor Xa inhibition) influence arrhythmia management strategies in this trial?